New study reveals novel multi-omics approach with unprecedented treatment response prediction in metastatic urothelial cancer

FHS
March 13, 2025
10:21 am

Novigenix, a leader in AI-driven healthcare solutions, has published a groundbreaking study showcasing the predictive power of its LITOSeek™ platform for immunotherapy response in metastatic urothelial cancer.

Dyne details pivotal plans for myotonic dystrophy RNA drug, though data blip worries some investors

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 11, 2025

AI Model Predicts Heart Disease and Heart Failure, Identifies $1.4B in Potential Savings

What You Should Know: – Cedar Gate Technologies (Cedar Gate), a leader in value-based care technology, announced today the potential for significant healthcare cost savings

May 2, 2024

Where Oak HC/FT investor Nancy Brown is placing her bets on AI in health tech

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.